Actualités Shengtai Pharmaceutical Inc (GM) - SGTI | Actions OTCMarkets

Outils de qualité professionnelle, pour des investisseurs individuels.

Statement of Ownership (sc 13g)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange...

Shengtai Pharmaceutical, Inc. Reports First Quarter Fiscal Year 2013 Financial Results

Shengtai Pharmaceutical, Inc. Reports First Quarter Fiscal Year 2013 Financial Results /* Style Definitions */ span.prnews_span { font-size:8pt...

- Quarterly Report (10-Q)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) x QUARTERLY...

Rosen Law Firm Announces Investigation of Shengtai Pharmaceutical In Connection With Going Private Proposal from its Chairman...

The Rosen Law Firm is investigating the Board of Directors of Shengtai Pharmaceutical Inc. (OTC: SGTI) for possible breaches of...

Shengtai Pharmaceutical, Inc. Reports Financial Results for the Fiscal Year 2012

Shengtai Pharmaceutical, Inc. Reports Financial Results for the Fiscal Year 2012 PR Newswire WEIFANG, Shandong, China, Sept. 28, 2012 WEIFANG...

- Annual Report (10-K)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 (Mark One) FORM 10 -K x ANNUAL REPORT PURSUANT TO...

- Current report filing (8-K)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section...

Shengtai Pharmaceutical, Inc. Special Committee Selects Financial and Legal Advisors

Shengtai Pharmaceutical, Inc. Special Committee Selects Financial and Legal Advisors PR Newswire WEIFANG, Shandong, China, June 23, 2012 WEIFANG...

Shengtai Pharmaceutical, Inc. Reports Third Quarter Fiscal Year 2012 Financial Results

Shengtai Pharmaceutical, Inc. Reports Third Quarter Fiscal Year 2012 Financial Results PR Newswire WEIFANG, China, May 16, 2012...

- Quarterly Report (10-Q)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) x...

- Current report filing (8-K)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR...

Shengtai Pharmaceutical, Inc. Establishes Special Committee to Evaluate Non-binding Going Private Proposal

Shengtai Pharmaceutical, Inc. Establishes Special Committee to Evaluate Non-binding Going Private Proposal PR Newswire WEIFANG, China, April 23...

- Current report filing (8-K)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR...

Forums

Afficher les forums

Aucune Discussion Trouvée

Ajouter une Discussion

Donnée du Marché

Actualité

Outils

Donnée du Marché

Discover

Hot Features

Follow Feed

Flux des Options

Moniteur

Shengtai Pharmaceutical Inc (GM) (SGTI)

Outils de qualité professionnelle, pour des investisseurs individuels.

SGTI Actualités

Statement of Ownership (sc 13g)

Shengtai Pharmaceutical, Inc. Reports First Quarter Fiscal Year 2013 Financial Results

- Quarterly Report (10-Q)

Rosen Law Firm Announces Investigation of Shengtai Pharmaceutical In Connection With Going Private Proposal from its Chairman...

Shengtai Pharmaceutical, Inc. Reports Financial Results for the Fiscal Year 2012

- Annual Report (10-K)

- Current report filing (8-K)

Shengtai Pharmaceutical, Inc. Special Committee Selects Financial and Legal Advisors

Shengtai Pharmaceutical, Inc. Reports Third Quarter Fiscal Year 2012 Financial Results

- Quarterly Report (10-Q)

- Current report filing (8-K)

Shengtai Pharmaceutical, Inc. Establishes Special Committee to Evaluate Non-binding Going Private Proposal

- Current report filing (8-K)

Forums

Dernières Valeurs Consultées

Société

Entreprise

Popular

Obtenir l'application

Donnée du Marché

Actualité

Outils

Donnée du Marché

Discover

Hot Features

Follow Feed

Flux des Options

Moniteur

Shengtai Pharmaceutical Inc (GM) (SGTI) Actualités

Shengtai Pharmaceutical Inc (GM) (SGTI)

Outils de qualité professionnelle, pour des investisseurs individuels.

SGTI Actualités

Statement of Ownership (sc 13g)

Shengtai Pharmaceutical, Inc. Reports First Quarter Fiscal Year 2013 Financial Results

- Quarterly Report (10-Q)

Rosen Law Firm Announces Investigation of Shengtai Pharmaceutical In Connection With Going Private Proposal from its Chairman...

Shengtai Pharmaceutical, Inc. Reports Financial Results for the Fiscal Year 2012

- Annual Report (10-K)

- Current report filing (8-K)

Shengtai Pharmaceutical, Inc. Special Committee Selects Financial and Legal Advisors

Shengtai Pharmaceutical, Inc. Reports Third Quarter Fiscal Year 2012 Financial Results

- Quarterly Report (10-Q)

- Current report filing (8-K)

Shengtai Pharmaceutical, Inc. Establishes Special Committee to Evaluate Non-binding Going Private Proposal

- Current report filing (8-K)

Forums

Dernières Valeurs Consultées

Société

Entreprise

Popular

Obtenir l'application

Supprimer les publicités